Skip to main content
. 2020 Mar 14;10(5):e01577. doi: 10.1002/brb3.1577

Figure 2.

Figure 2

Comparison between the role of amylin (IAPP) in T2DM patients and Aβ (beta‐amyloid) in AD patients. It supports the fact that the dysfunction and accumulation of Amyloidogenic peptides are common causes for both the pathologies. Amylin is now considered as one of the prominent links in the molecular mechanism of glucose‐mediated neurodegeneration